Filing Flows › Lifevantage (LFVN) › Q1 2026 › vs Q1 2025
Lifevantage (LFVN) Q1 2026 vs Q1 2025 (year over year)
Lifevantage's revenue fell $14.7M (-25%) from $58.4M in Q1 2025 to $43.7M in Q1 2026. The biggest changes: Life Vantage Product Line −$10.0M (-61%); Protandim −$3.5M (-15%); Love Biome Product Line +$3.2M (—). Gross margin 79.0% against 81.0% (-2.0 pts).
Lifevantage, Q1 2026: revenue $43.7M (-25% year over year), operating margin 3.8%, net earnings $1.4M, operating cash flow $5.0M. The chart draws each line against Q1 2025, the increases inside each band.
Margins
| Q1 2026 | Q1 2025 | Change | |
|---|---|---|---|
| Gross margin | 79.0% | 81.0% | -2.0 pts |
| Operating margin | 3.8% | 6.9% | -3.1 pts |
| Net margin | 3.1% | 5.9% | -2.8 pts |
| Free cash flow margin | 9.1% | 3.2% | +5.9 pts |
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Protandim | $20.0M | $23.5M | −$3.5M | -15% |
| True Science Product Line | $8.9M | $11.7M | −$2.8M | -24% |
| Life Vantage Product Line | $6.3M | $16.3M | −$10.0M | -61% |
| AXIO Product Line | $3.4M | $3.9M | −$462K | -12% |
| Love Biome Product Line | $3.2M | $0 | $3.2M | — |
| Phys IQ Product Line | $847K | $1.4M | −$518K | -38% |
| Product and Service Other | $632K | $1.2M | −$534K | -46% |
| Petandim Product Line | $466K | $553K | −$87K | -16% |
| Revenue | $43.7M | $58.4M | −$14.7M | -25% |
| Gross profit | $34.5M | $47.3M | −$12.8M | -27% |
| Cost of revenue | $9.2M | $11.1M | −$1.9M | -17% |
| Operating profit | $1.7M | $4.1M | −$2.4M | -59% |
| Operating expenses | $32.9M | $43.3M | −$10.4M | -24% |
| Pre-tax earnings | $1.7M | $4.2M | −$2.5M | -60% |
| Research & development | $200K | $400K | −$200K | -50% |
| SG&A | $13.9M | $17.1M | −$3.2M | -19% |
| Other operating costs | $18.8M | $25.8M | −$7.0M | -27% |
| Net earnings | $1.4M | $3.5M | −$2.1M | -61% |
| Income tax | $294K | $710K | −$416K | -59% |
| Depreciation & amortization | $714K | $803K | −$89K | -11% |
| Share-based compensation | $704K | $1.5M | −$817K | -54% |
| Working capital & other | $2.2M | −$3.6M | $5.8M | — |
| Operating cash flow | $5.0M | $2.2M | $2.8M | +124% |
| Free cash flow (OCF − capex) | $4.0M | $1.9M | $2.1M | +110% |
| Capital expenditures | $1.0M | $331K | $680K | +205% |
Questions
How much did Lifevantage's revenue grow year over year in Q1 2026?
Lifevantage's revenue fell $14.7M (-25%) from $58.4M in Q1 2025 to $43.7M in Q1 2026.
What drove Lifevantage's revenue change in Q1 2026?
Life Vantage Product Line −$10.0M (-61%); Protandim −$3.5M (-15%); Love Biome Product Line +$3.2M (—).